Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes. - Parinyanitikul N; Lei X; Chavez-MacGregor M; Liu S; Mittendorf EA; Litton JK; Woodward W; Zhang AH; Hortobagyi GN; Valero V; Meric-Bernstam F; Gonzalez-Angulo AM (Clinical breast cancer, 2015)